Catherine Noguès

12.8k total citations
89 papers, 2.5k citations indexed

About

Catherine Noguès is a scholar working on Genetics, Oncology and Molecular Biology. According to data from OpenAlex, Catherine Noguès has authored 89 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Genetics, 32 papers in Oncology and 19 papers in Molecular Biology. Recurrent topics in Catherine Noguès's work include BRCA gene mutations in cancer (58 papers), Family Support in Illness (12 papers) and Cancer Genomics and Diagnostics (11 papers). Catherine Noguès is often cited by papers focused on BRCA gene mutations in cancer (58 papers), Family Support in Illness (12 papers) and Cancer Genomics and Diagnostics (11 papers). Catherine Noguès collaborates with scholars based in France, United States and Canada. Catherine Noguès's co-authors include Rosette Lidereau, Ivan Bièche, Michel Vidaud, Hagay Sobol, François Eisinger, Claire Julian‐Reynier, Martine Olivi, Philippe Vennin, Olivier Caron and Dominique Stoppa‐Lyonnet and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Catherine Noguès

84 papers receiving 2.4k citations

Peers

Catherine Noguès
Catherine Noguès
Citations per year, relative to Catherine Noguès Catherine Noguès (= 1×) peers François Eisinger

Countries citing papers authored by Catherine Noguès

Since Specialization
Citations

This map shows the geographic impact of Catherine Noguès's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Noguès with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Noguès more than expected).

Fields of papers citing papers by Catherine Noguès

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Noguès. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Noguès. The network helps show where Catherine Noguès may publish in the future.

Co-authorship network of co-authors of Catherine Noguès

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Noguès. A scholar is included among the top collaborators of Catherine Noguès based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Noguès. Catherine Noguès is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leman, Raphaël, Laurent Castéra, Virginie Bernard, et al.. (2025). Identification of a germline deep intronic PTEN-deletion leading to exonization through whole genome and targeted RNA sequencing. Familial Cancer. 24(1). 21–21.
2.
Sandoval, Renata Lazari, Michele Bottosso, Tianyu Li, et al.. (2024). TP53-associated early breast cancer: new observations from a large cohort. JNCI Journal of the National Cancer Institute. 116(8). 1246–1254. 6 indexed citations
3.
Blein, Sophie, Laure Barjhoux, Francesca Damiola, et al.. (2015). Targeted Sequencing of the Mitochondrial Genome of Women at High Risk of Breast Cancer without Detectable Mutations in BRCA1/2. PLoS ONE. 10(9). e0136192–e0136192. 9 indexed citations
4.
Mancini, Julien, Emmanuelle Mouret‐Fourme, Catherine Noguès, & Claire Julian‐Reynier. (2014). Impact of BRCA1/2 mutation on young women’s 5-year parenthood rates: a prospective comparative study (GENEPSO-PS cohort). Familial Cancer. 14(2). 273–279. 3 indexed citations
5.
Hassanein, Mohamed, Laëtitia Huiart, Violaine Bourdon, et al.. (2013). Prediction of BRCA1 Germ-Line Mutation Status in Patients with Breast Cancer Using Histoprognosis Grade, MS110, Lys27H3, Vimentin, and KI67. Pathobiology. 80(5). 219–227. 10 indexed citations
6.
Eisinger, François, et al.. (2012). Spontaneous disclosure of BRCA1/2 genetic test results to employers: a French prospective study. European Journal of Human Genetics. 20(9). 981–983. 5 indexed citations
7.
Muller, Danièle, Étienne Rouleau, Sandrine M. Caputo, et al.. (2011). An entire exon 3 germ-line rearrangement in the BRCA2 gene: pathogenic relevance of exon 3 deletion in breast cancer predisposition. BMC Medical Genetics. 12(1). 121–121. 15 indexed citations
8.
Julian‐Reynier, Claire, Anne‐Déborah Bouhnik, Christine Lasset, et al.. (2010). Time to prophylactic surgery in BRCA1/2 carriers depends on psychological and other characteristics. Genetics in Medicine. 12(12). 801–807. 30 indexed citations
9.
Coulet, Florence, Étienne Rouleau, Cédrick Lefol, et al.. (2010). A One-Step Prescreening for Point Mutations and Large Rearrangement in BRCA1 and BRCA2 Genes Using Quantitative Polymerase Chain Reaction and High-Resolution Melting Curve Analysis. Genetic Testing and Molecular Biomarkers. 14(5). 677–690. 16 indexed citations
10.
Jackson, Amanda, Akeila Bellahcène, Nadia Rucci, et al.. (2008). A Six-Gene Signature Predicting Breast Cancer Lung Metastasis. Cancer Research. 68(15). 6092–6099. 121 indexed citations
11.
Chompret, Agnès, Catherine Noguès, & Dominique Stoppa‐Lyonnet. (2007). Consultation d'oncogénétique pour le cancer du sein. La Presse Médicale. 36(2). 357–363. 1 indexed citations
12.
Eisinger, François, Brigitte Bressac–de Paillerets, Damienne Castaigne, et al.. (2006). Identification et prise en charge des prédispositions héréditaires aux cancers du sein et de l'ovaire (mise à jour 2004). Pathologie Biologie. 54(4). 230–250. 76 indexed citations
13.
Mancini, Julien, Catherine Noguès, Claude Adenis, et al.. (2006). Impact of an information booklet on satisfaction and decision-making about BRCA genetic testing. European Journal of Cancer. 42(7). 871–881. 39 indexed citations
14.
Rouëssé, Jacques, Brigitte De La Lande, F. Bertheault-Cvitkovic, et al.. (2006). A phase III randomized trial comparing adjuvant concomitant chemoradiotherapy versus standard adjuvant chemotherapy followed by radiotherapy in operable node-positive breast cancer: Final results. International Journal of Radiation Oncology*Biology*Physics. 64(4). 1072–1080. 53 indexed citations
15.
Eisinger, François, Brigitte Bressac–de Paillerets, Damienne Castaigne, et al.. (2004). Identification and management of hereditary breast\ovarian cancers (2004 update). Bulletin du Cancer. 91(3). 219–237. 1 indexed citations
16.
Eisinger, François, Brigitte Bressac–de Paillerets, J. Lansac, et al.. (2004). Réponse du Groupe technique national sur le dépistage du cancer du sein. Bulletin du Cancer. 91(7). 656–656. 1 indexed citations
17.
Sobol, Hagay, Yves‐Jean Bignon, Catherine Bonaïti, et al.. (1999). Four Years Analysis of Cancer Genetic Clinics Activity in France from 1994 to 1997: A Survey on 801 Patients. Disease Markers. 15(1-3). 15–29. 12 indexed citations
18.
Bièche, Ivan, Catherine Noguès, & Rosette Lidereau. (1999). Overexpression of BRCA2 gene in sporadic breast tumours. Oncogene. 18(37). 5232–5238. 67 indexed citations
19.
Bièche, Ivan, et al.. (1997). Prognostic value of loss of heterozygosity at BRCA2 in human breast carcinoma. British Journal of Cancer. 76(11). 1416–1418. 15 indexed citations
20.
Julian‐Reynier, Claire, François Eisinger, F Chabal, et al.. (1996). Cancer genetics clinics: Target population and consultees' expectations. European Journal of Cancer. 32(3). 398–403. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026